321.71
Penumbra Inc Borsa (PEN) Ultime notizie
Penumbra, Inc. Reports Third Quarter 2025 Financial Results - Quantisnow
Penumbra Shareholders Approve Merger with Boston Scientific - The Globe and Mail
Penumbra revenue up 15.6% to USD 374.8M in Q1 2026 - Medical Buyer
PEN Maintained by Citigroup -- Price Target Lowered to $350 - GuruFocus
Penumbra (PEN) Margin Expansion To 11.8% Tests Bulls High P E Narrative - Sahm
Citi Maintains Penumbra(PEN.US) With Hold Rating, Cuts Target Price to $350 - Moomoo
Penumbra Is Maintained at Outperform by Evercore ISI Group - Moomoo
Liquidity Mapping Around (PEN) Price Events - Stock Traders Daily
PEN Maintained by Evercore ISI Group -- Price Target Lowered to $335 - GuruFocus
Penumbra Is a 'Strong' Strategic Fit for Boston Scientific, RBC Says - Moomoo
Penumbra shareholders approve merger with Boston Scientific By Investing.com - Investing.com Australia
Penumbra, Inc. Q1 2026 Financial Results: Earnings, Comprehensive Income, and Stockholders’ Equity Highlights - Minichart
Penumbra IncStockholders approve merger with Boston ScientificSEC filing - marketscreener.com
Penumbra shareholders approve merger with Boston Scientific - Investing.com
Penumbra (NYSE: PEN) shareholders approve Merger Proposal; closing conditions remain - Stock Titan
Penumbra (NYSE: PEN) investors back merger, await antitrust approvals - Stock Titan
Evercore Maintains Penumbra(PEN.US) With Buy Rating, Cuts Target Price to $335 - Moomoo
Penumbra: Q1 Earnings Snapshot - theheraldreview.com
Assessing Penumbra (PEN) Valuation As Growth Expectations Meet A Premium P/E Multiple - Yahoo Finance
PEN Stock Price, Quote & Chart | PENUMBRA INC (NYSE:PEN) - ChartMill
Penumbra Shareholder Notice - TMX Newsfile
MSN Money - MSN
Penumbra (PEN) Misses Q1 Earnings Estimates - Yahoo Finance
[10-Q] Penumbra Inc Quarterly Earnings Report - Stock Titan
Earnings Flash (PEN) Penumbra, Inc. Reports Q1 Revenue $374.8M, vs. FactSet Est of $371.3M - marketscreener.com
Penumbra (NYSE: PEN) posts $374.8M Q1 2026 revenue as Boston Scientific deal looms - Stock Titan
Penumbra posts $32.6M profit as Boston Scientific deal halts outlook - Stock Titan
Penumbra, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
PEN Technical Analysis | Trend, Signals & Chart Patterns | PENUMBRA INC (NYSE:PEN) - ChartMill
Penumbra earnings in focus as Boston Scientific deal looms By Investing.com - Investing.com South Africa
Penumbra earnings in focus as Boston Scientific deal looms - Investing.com
Penumbra, Inc. (PEN) Stock Analysis: A 12.44% Potential Upside in the Thriving Medical Devices Sector - DirectorsTalk Interviews
Vanguard Group Inc. Cuts Stock Position in Penumbra, Inc. $PEN - MarketBeat
Inside Boston Scientific's $15 billion offer for Alameda's largest employer - The Business Journals
Penumbra, Inc. (NYSE:PEN) Sees Large Drop in Short Interest - MarketBeat
Vanguard Capital Management (NYSE: PEN) holds 1.99M shares, 5.07% stake - Stock Titan
[ARS] Penumbra Inc SEC Filing - Stock Titan
Penumbra (PEN) down 1.6% since last earnings report: Can it rebound? - MSN
Penumbra (NYSE: PEN) outlines 2026 meeting and $14.5B Boston Scientific sale - Stock Titan
Teacher Retirement System of Texas Reduces Stake in Penumbra, Inc. $PEN - MarketBeat
3 Reasons Why Penumbra (PEN) Is a Great Growth Stock - Yahoo Finance
Investor Outlook: Penumbra, Inc. (PEN) Eyes 10.88% Upside With Strong Revenue Growth - DirectorsTalk Interviews
A Look At Penumbra (PEN) Valuation After Positive STORM PE Trial Outcomes - Sahm
Why (PEN) Price Action Is Critical for Tactical Trading - Stock Traders Daily
How STORM-PE Thrombectomy Results and Lightning Flash Data Will Impact Penumbra (PEN) Investors - simplywall.st
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):